Which treatment approach is NOT a pharmacological intervention for treating depression in stroke patients?

Cognitive Behavioral Therapy (CBT) is recognized as a psychotherapeutic approach rather than a pharmacological intervention. In the context of treating depression in stroke patients, CBT focuses on addressing negative thought patterns and behaviors, helping patients develop coping strategies, and promoting positive changes in their mindset. This approach is centered on psychotherapy rather than medication.

Conversely, the other options—Electroconvulsive Therapy, Repetitive Transcranial Magnetic Stimulation, and medication prescribed by a doctor—are all classified as pharmacological or biologically based interventions. Electroconvulsive Therapy is a medical treatment for severe depression that involves electrical stimulation of the brain, while Repetitive Transcranial Magnetic Stimulation uses magnetic fields to stimulate nerve cells. Medication, such as antidepressants, is also a typical pharmacological approach to treating depression. Thus, the focus of CBT on behavioral and cognitive strategies distinguishes it from these pharmacological treatments.